Taken together, these results demonstrate a critical role of melanoma cell-intrinsic FTO in promotinging melanoma resistance to anti-PD-1 blockade, suggesting that FTO inhibition can reduce resistance to anti-PD-1 therapy (Fig. 8m). Here, PDCD1 is linked to melanoma.